1. Establishment and Characterization of a Brca1−/−, p53−/− Mouse Mammary Tumor Cell Line
   Lilla Hámori et al, 2020, International Journal of Molecular Sciences CrossRef
2. MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
   Kristijan Skok et al, 2021, Cells CrossRef
3. Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes
   Shijiao Ma et al, 2022, International Journal of Nanomedicine CrossRef
4. Gynaecological cancers and their cell lines
   Kristijan Skok et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
5. In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment
   Zohra Benyahia et al, 2021, Cancers CrossRef
6. Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro
   Mª Jesús Núñez-Iglesias et al, 2021, International Journal of Molecular Sciences CrossRef
7. Hyperstabilization of T cell microvilli contacts by chimeric antigen receptors
   Casey Beppler et al, 2023, Journal of Cell Biology CrossRef
8. Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells
   Mostafa A. Aboouf et al, 2022, International Journal of Molecular Sciences CrossRef
9. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage
   Anna L. Greenshields et al, 2019, BioMetals CrossRef
10. Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives
    Harishini Rajaratinam et al, 2022, Biomolecules CrossRef
11. Expression of Breast Cancer Subtypes Based on the Most Important Biomarkers: Comparison of Clinicopathological Factors and Survival
    Mohammad Hadizadeh et al, 2018, Iranian Red Crescent Medical Journal CrossRef
12. The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
    Arpit Dave et al, 2023, Cellular Oncology CrossRef
13. Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with 177Lu Is More Potent for Killing Human Breast Cancer Cells That Coexpress HER2 and EGFR Than Single-Receptor-Targeted (SRT) Radiation Nanomedicines
    Simmyung Yook et al, 2020, Molecular Pharmaceutics CrossRef
14. Nuclear Deformability of Breast Cells Analyzed from Patients with Malignant and Benign Breast Diseases
    Ezgi Antmen et al, 2023, ACS Biomaterials Science & Engineering CrossRef
15. Image-based phenotyping of disaggregated cells using deep learning
    Samuel Berryman et al, 2020, Communications Biology CrossRef
16. The g3mclass is a practical software for multiclass classification on biomarkers
    Marina A. Guvakova et al, 2022, Scientific Reports CrossRef
17. Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
    Mian Huang et al, 2023, International Journal of Nanomedicine CrossRef
18. The Aryl Hydrocarbon Receptor Undergoes Chaperone-Mediated Autophagy in Triple-Negative Breast Cancer Cells
    Jinyun Chen et al, 2021, International Journal of Molecular Sciences CrossRef
19. Anticancer potential of turmeric (Curcuma longa) ethanol extract and prediction of its mechanism through the Akt1 pathway
    Muhammad Hermawan Widyananda et al, 2022, F1000Research CrossRef
20. Comparison of Hydrogels for the Development of Well-Defined 3D Cancer Models of Breast Cancer and Melanoma
    Rafael Schmid et al, 2020, Cancers CrossRef